AN2 Therapeutics director Margaret M. FitzPatrick acquires 2,098 common shares worth $11,602.94

• AN2 Therapeutics director Margaret M. FitzPatrick bought 2,098 common shares at USD 5.53 each, a Form 4 filing shows.
• Her direct holding rose to 10,708 shares following the purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-380595), on September 02, 2026, and is solely responsible for the information contained therein.